Medtronic's diabetes unit MiniMed raises $560 million in US IPO
Reuters03-06 08:39
Medtronic's diabetes unit MiniMed raises $560 million in US IPO
March 5 (Reuters) - MiniMed, the diabetes business of medical device maker Medtronic MDT.N, said on Thursday it has raised $560 million in its U.S. initial public offering.
(Reporting by Manya Saini in Bengaluru and Carlos Méndez in Mexico City; Editing by Sumana Nandy and Sahal Muhammed)
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments